GLMD vs. SPCB
GLMD (Galmed Pharmaceuticals Ltd.) and SPCB (SuperCom Ltd.) are both stocks. GLMD operates in Biotechnology (Healthcare), while SPCB operates in Security & Protection Services (Industrials). Over the past 10 years, GLMD returned -51.88%/yr vs -34.67%/yr for SPCB. At a 0.10 correlation, their price movements are largely independent.
Performance
GLMD vs. SPCB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GLMD achieves a -23.78% return, which is significantly lower than SPCB's 20.11% return. Over the past 10 years, GLMD has underperformed SPCB with an annualized return of -51.88%, while SPCB has yielded a comparatively higher -34.67% annualized return.
GLMD
- 1D
- 1.40%
- 1M
- -1.40%
- YTD
- -23.78%
- 6M
- -35.00%
- 1Y
- -67.31%
- 3Y*
- -75.82%
- 5Y*
- -74.72%
- 10Y*
- -51.88%
SPCB
- 1D
- -0.50%
- 1M
- -1.36%
- YTD
- 20.11%
- 6M
- 9.91%
- 1Y
- 7.09%
- 3Y*
- -18.93%
- 5Y*
- -47.40%
- 10Y*
- -34.67%
GLMD vs. SPCB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | -23.78% | -76.47% | -41.58% | -93.93% | -72.53% | -41.48% | -46.19% | -15.37% | -25.36% | 160.68% |
SPCB SuperCom Ltd. | 20.11% | 87.76% | -37.60% | -78.30% | -67.93% | -46.12% | 66.13% | -55.07% | -64.71% | 15.34% |
Correlation
The correlation between GLMD and SPCB is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Mar 13, 2014 | 0.10 |
Fundamentals
GLMD:
$3.76M
SPCB:
$53.96M
GLMD:
-$1.93
SPCB:
$0.94
GLMD:
0.24
SPCB:
1.24
GLMD:
$0.00
SPCB:
$27.90M
GLMD:
$0.00
SPCB:
$15.39M
GLMD:
-$8.49M
SPCB:
$4.32M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLMD vs. SPCB — Risk / Return Rank
GLMD
SPCB
GLMD vs. SPCB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and SuperCom Ltd. (SPCB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLMD | SPCB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.82 | ||
| Sortino ratioReturn per unit of downside risk | -1.70 | ||
| Omega ratioGain probability vs. loss probability | 0.88 | 1.08 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.84 | 0.16 | -1.00 |
| Martin ratioReturn relative to average drawdown | -1.16 | 0.27 | -1.44 |
Loading charts...
Drawdowns
GLMD vs. SPCB - Drawdown Comparison
The maximum GLMD drawdown since its inception was -99.99%, roughly equal to the maximum SPCB drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for GLMD and SPCB.
Loading charts...
Drawdown Indicators
| GLMD | SPCB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -99.98% | -0.01% |
Max Drawdown (1Y)Largest decline over 1 year | -79.86% | -45.37% | -34.49% |
Max Drawdown (3Y)Largest decline over 3 years | -98.84% | -86.81% | -12.03% |
Max Drawdown (5Y)Largest decline over 5 years | -99.92% | -99.03% | -0.89% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | -99.69% | -0.30% |
Current DrawdownCurrent decline from peak | -99.98% | -99.91% | -0.07% |
Average DrawdownAverage peak-to-trough decline | -76.07% | -91.50% | +15.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 58.02% | 25.86% | +32.16% |
Volatility
GLMD vs. SPCB - Volatility Comparison
Galmed Pharmaceuticals Ltd. (GLMD) has a higher volatility of 49.40% compared to SuperCom Ltd. (SPCB) at 24.50%. This indicates that GLMD's price experiences larger fluctuations and is considered to be riskier than SPCB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLMD | SPCB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 49.40% | 24.50% | +24.90% |
Volatility (6M)Calculated over the trailing 6-month period | 74.20% | 46.74% | +27.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.71% | 68.86% | +24.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 166.70% | 122.49% | +44.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 138.16% | 114.77% | +23.39% |
Dividends
GLMD vs. SPCB - Dividend Comparison
Neither GLMD nor SPCB has paid dividends to shareholders.
Financials
GLMD vs. SPCB - Financials Comparison
This section allows you to compare key financial metrics between Galmed Pharmaceuticals Ltd. and SuperCom Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
GLMD and SPCB have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GLMD has higher volatility (49.40%) compared to SPCB (24.50%). In terms of maximum drawdown, GLMD dropped -99.99% vs SPCB's -99.98%.
SPCB currently has the higher Sharpe Ratio (0.10 vs -0.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GLMD and SPCB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer